Invasa Pharmaceuticals Private Limited

Invasa Pharmaceuticals Private Limited - chemicals in Bhopal, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24239MP2021PTC056618 Incorporated 08 July 2021 ROC Gwalior HQ Bhopal, Madhya Pradesh, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2024
₹2.76 Lakh
▲ 5% YoY
Net loss · FY 2024
₹26,090
Net margin -9.4%
EBITDA · FY 2024
-₹26,090
EBITDA margin -9.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Invasa Pharmaceuticals Private Limited

Data last updated:

Invasa Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 08 July 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2021PTC056618.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhavna Premchandani and Aman Kumar Premchandani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 Chhawni Shop No – 3 H No – 10 I Wali Gali, Bhopal, Madhya Pradesh, India – 462001.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.76 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹26,090 (net margin -9.4%) and EBITDA of -₹26,090 (EBITDA margin -9.4%).

Company details

CIN U24239MP2021PTC056618
Registration Number 056618
Incorporation Date 08 July 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Invasa Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh.

  • Registered Address
    3 Chhawni Shop No – 3 H No – 10 I Wali Gali, Bhopal, Madhya Pradesh, India – 462001
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Invasa Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Invasa Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Invasa Pharmaceuticals Private Limited, buy the company report.

Financials of Invasa Pharmaceuticals Private Limited

FY 2025 filings available

Invasa Pharmaceuticals Private Limited reported revenue of ₹2.76 Lakh (up 5% YoY) for FY 2024.

Revenue · FY 2024
₹2.76 Lakh ▲ 5%
Net loss · FY 2024
₹26,090 margin -9.4%
EBITDA · FY 2024
-₹26,090 margin -9.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
EBITDA CAGR growth
1 year
▲ 12%

Revenue rose 5% in the latest year. EBITDA rose 12% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹26,090
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹26,090
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin-9.4%
Net Profit Margin-9.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Invasa Pharmaceuticals Private Limited, buy the company report.

Board of directors of Invasa Pharmaceuticals Private Limited

Invasa Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhavna PremchandaniDirector08 Jul 20215 Years 3 MonthsCurrent
Aman Kumar PremchandaniDirector08 Jul 20215 Years 3 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Invasa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Invasa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Invasa Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Aman Kumar Premchandani was appointed as Director on 08 Jul 2021.

AGM
Invasa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Invasa Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Aman Kumar Premchandani was appointed as Director.
Appointed
Bhavna Premchandani was appointed as Director.
Incorporation
08 Jul 2021
Invasa Pharmaceuticals Private Limited was registered on 08 Jul 2021 with Roc Gwalior & aged 5 years 3 months as per MCA records.

Frequently asked questions

Invasa Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 08 July 2021 (5+ years old) and is registered under CIN U24239MP2021PTC056618.

Invasa Pharmaceuticals has 2 current directors:

The latest financial statements of Invasa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.

The CIN (Corporate Identification Number) of Invasa Pharmaceuticals is U24239MP2021PTC056618. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Invasa Pharmaceuticals was incorporated on 08 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.

Aman Kumar Premchandani was appointed as Director on 08 Jul 2021. Bhavna Premchandani was appointed as Director on 08 Jul 2021.

The registered office of Invasa Pharmaceuticals is at 3 Chhawni Shop No – 3 H No – 10 I Wali Gali, Bhopal, Madhya Pradesh, India – 462001.

Invasa Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

Invasa Pharmaceuticals can be reached at its registered office: 3 Chhawni Shop No – 3 H No – 10 I Wali Gali, Bhopal, Madhya Pradesh, India – 462001.

Invasa Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.